The global Respiratory Syncytial Virus (RSV) therapeutics market size stood at USD 1,111.3 million in 2019. The global impact of COVID-19 has been unprecedented and staggering, with RSV drugs experiencing a negative demand shock across all regio

https://www.fortunebusinessinsights.com/respiratory-syncytial-virus-rsv-therapeutics-market-104668